Algorae Pharmaceuticals Limited Share Price
Equities
1AI
AU0000296022
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 AUD | 0.00% | -9.09% | 0.00% |
08/03 | Algorae Pharmaceuticals Nears Launch of Drug Discovery Platform | MT |
28/02 | Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 3.4K 2.22K 185K | Sales 2023 | 42.02K 27.44K 2.29M | Capitalization | 23.4M 15.29M 1.27B |
---|---|---|---|---|---|
Net income 2022 | -1M -653K -54.46M | Net income 2023 | -2M -1.31M -109M | EV / Sales 2022 | 1,775 x |
Net cash position 2022 | 4.24M 2.77M 231M | Net cash position 2023 | 4.11M 2.69M 224M | EV / Sales 2023 | 459 x |
P/E ratio 2022 |
-3.58
x | P/E ratio 2023 |
-9.38
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.39% |
1 week | -9.09% | ||
3 months | +11.11% | ||
6 months | -16.67% |
Managers | Title | Age | Since |
---|---|---|---|
Daya Uka
DFI | Director of Finance/CFO | - | 01/16/01 |
James Mckenna
CTO | Chief Tech/Sci/R&D Officer | - | 19/23/19 |
Chief Operating Officer | - | 13/21/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hainsworth
CHM | Chairman | 50 | 31/22/31 |
Bradley Dilkes
BRD | Director/Board Member | 39 | 31/22/31 |
Bradley Latham
BRD | Director/Board Member | 62 | 03/23/03 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.01 | 0.00% | 1,835,709 |
24/24/24 | 0.01 | 0.00% | 1,581,361 |
23/24/23 | 0.01 | 0.00% | 1,294,618 |
22/24/22 | 0.01 | -9.09% | 2,268,829 |
19/24/19 | 0.011 | 0.00% | 4,427,760 |
Delayed Quote Australian S.E., April 26, 2024 at 11:40 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 11M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 1AI Stock